Search Results - "Neurohr, C"

Refine Results
  1. 1

    Challenge of the supercritical antisolvent technique SAS to prepare cocrystal-pure powders of naproxen-nicotinamide by Neurohr, C., Erriguible, A., Laugier, S., Subra-Paternault, P.

    “…•Cocrystals-pure powders was produced using CO2 as antisolvent.•Providing a feed flows combination between 2 and 11.•Whereas a flow ratio of 36 yielded…”
    Get full text
    Journal Article
  2. 2

    What rheumatologists can learn from pneumologists by Leuschner, G, Neurohr, C

    Published in Zeitschrift für Rheumatologie (01-08-2018)
    “…Pulmonary involvement in patients with underlying autoimmune diseases poses a major diagnostic and therapeutic challenge to the treating physician. Due to the…”
    Get full text
    Journal Article
  3. 3

    Inhalation of vasoactive intestinal peptide in pulmonary hypertension by Leuchte, H. H, Baezner, C, Baumgartner, R. A, Bevec, D, Bacher, G, Neurohr, C, Behr, J

    Published in The European respiratory journal (01-11-2008)
    “…Pulmonary hypertension (PH) leads to an increased right ventricular workload, cardiac failure and death. In idiopathic pulmonary arterial hypertension (PAH)…”
    Get full text
    Journal Article
  4. 4

    Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertension by Meinel, F G, Graef, A, Thierfelder, K M, Armbruster, M, Schild, C, Neurohr, C, Reiser, M F, Johnson, T R C

    “…The aim of the study was to determine whether automated quantification of pulmonary perfused blood volume (PBV) in dual-energy computed tomography pulmonary…”
    Get more information
    Journal Article
  5. 5

    Posaconazole liquid vs tablet formulation in lung transplant recipients by Stelzer, D., Weber, A., Ihle, F., Matthes, S., Ceelen, F., Zimmermann, G., Kneidinger, N., Schramm, R., Winter, H., Zoller, M., Vogeser, M., Behr, J., Neurohr, C.

    Published in Mycoses (01-03-2018)
    “…Summary Posaconazole is an extended‐spectrum triazole antifungal used in the treatment and prophylaxis of Aspergillus infections. It is available as oral…”
    Get full text
    Journal Article
  6. 6

    Cocrystallization induced by compressed CO2 as antisolvent: Simulation of a batch process for the estimation of nucleation and growth parameters by Erriguible, A., Neurohr, C., Revelli, A.-L., Laugier, S., Fevotte, G., Subra-Paternault, P.

    Published in The Journal of supercritical fluids (01-03-2015)
    “…•Cocrystals of naproxen and nicotinamide (2:1 stoichiometric ratio) were produced by CO2 antisolvent (GAS technique) with a size distribution below…”
    Get full text
    Journal Article
  7. 7

    Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany by Bergmann, Karl-Christian, Skowasch, Dirk, Timmermann, Hartmut, Lindner, Robert, Virchow, Johann Christian, Schmidt, Olaf, Koschel, Dirk, Neurohr, Claus, Heck, Sebastian, Milger, Katrin

    Published in Journal of asthma and allergy (01-01-2022)
    “…Purpose: Asthma is one of the most prevalent chronic diseases in Germany affecting 4-5% of all adults and 10% of children. Despite the availability of…”
    Get full text
    Journal Article
  8. 8

    Naproxen–nicotinamide cocrystals produced by CO2 antisolvent by Neurohr, C., Revelli, A.-L., Billot, P., Marchivie, M., Lecomte, S., Laugier, S., Massip, S., Subra-Paternault, P.

    Published in The Journal of supercritical fluids (01-11-2013)
    “…•Cocrystals of naproxen and nicotinamide were successfully prepared by CO2 antisolvent recrystallization.•The cocrystals content in product is quantified.•A…”
    Get full text
    Journal Article
  9. 9

    Usefulness of Exhaled Nitric Oxide to Guide Risk Stratification for Bronchiolitis Obliterans Syndrome After Lung Transplantation by Neurohr, C., Huppmann, P., Leuschner, S., von Wulffen, W., Meis, T., Leuchte, H., Ihle, F., Zimmermann, G., Baezner, C., Hatz, R., Winter, H., Frey, L., Ueberfuhr, P., Bittmann, I., Behr, J.

    Published in American journal of transplantation (01-01-2011)
    “…The aim of this study was to assess fractional exhaled nitric oxide (FeNO) for the early diagnosis of bronchiolitis obliterans syndrome (BOS) after lung…”
    Get full text
    Journal Article
  10. 10
  11. 11

    General and supportive therapy of pulmonary arterial hypertension by Grünig, E, Benjamin, N, Krüger, U, Kaemmerer, H, Harutyunova, S, Olsson, K M, Ulrich, S, Gerhardt, F, Neurohr, C, Sablotzki, A, Halank, M, Kabitz, H-J, Thimm, G, Fliegel, K-G, Klose, H

    Published in Deutsche medizinische Wochenschrift (1946) (01-10-2016)
    “…The 2015 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension are also valid for Germany. The guidelines contain detailed recommendations…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis by Behr, J, Bonella, F, Bonnet, R, Gläser, S, Grohé, C, Günther, A, Koschel, D, Kreuter, M, Kirsten, D, Krögel, C, Markart, P, Müller-Quernheim, J, Neurohr, C, Pfeifer, M, Prasse, A, Schönfeld, N, Schreiber, J, Wirtz, H, Witt, C, Costabel, U

    Published in Pneumologie (Stuttgart, Germany) (01-08-2015)
    “…Spirometry is a highly standardized method which allows to measure the forced vital capacity (FVC) with high precision and reproducibility. In patients with…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Rheumathism and pneumology by Jakubczyc, A, Neurohr, C

    Published in Der Orthopäde (01-11-2019)
    “…BACKGROUNDDue to the broad range of diagnostic and therapeutic aspects with an increased risk of mortality, lung manifestations of rheumatic diseases are an…”
    Get full text
    Journal Article
  19. 19
  20. 20